Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention
- 1 June 2004
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 43 (12), 2160-2165
- https://doi.org/10.1016/j.jacc.2004.02.047
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Oral Everolimus Inhibits In-Stent Neointimal GrowthCirculation, 2002
- Can we prevent in-stent restenosis?Current Opinion in Cardiology, 2002
- Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial)Journal of the American College of Cardiology, 1996
- A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplastyThe American Journal of Cardiology, 1994
- Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.Heart, 1994
- Effects of diltiazem on complications and restenosis after coronary angioplastyThe American Journal of Cardiology, 1991
- Re-Stenosis after Successful Coronary AngioplastyNew England Journal of Medicine, 1988
- Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1986
- Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1985
- Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.Cell Metabolism, 1985